Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Viatris's Gwyn Lo

Pharmaceutical Executive Daily: FDA Approves Viatris's Gwyn Lo

Published 3 months, 2 weeks ago
Description
In today's Pharmaceutical Executive Daily, a commentary examines why fragmented software tooling causes scientific judgment to get lost across the biologics R&D pipeline, Replimune shares crash nearly 32 percent after FDA reviewers raise concerns about its melanoma therapy, and FDA approves Viatris's Gwyn Lo as a new once-weekly contraceptive patch.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us